Possible Parkinson's treatment successfully targets two major nerve systems

January 21, 2020

Scientists have discovered that a non-invasive technique which could one day be used to treat Parkinson's disease, can successfully target a highly specific group of brain cells which play a key role in development of the condition.

In 2015, scientists demonstrated that a form of gene therapy could target and stimulate a group of nerve cells affected by the disease, called cholinergic neurons. These cells degenerate as the disease progresses.

Now, thanks to brain imaging technology, they have discovered that their method, which targets cells that produce specific brain chemicals, can also successfully stimulate another type of neuron through cell-to-cell interactions.

In a study published in the journal Neurotherapeutics, Dr Ilse Pienaar, Lecturer in Pharmacology at the University of Sussex, along with colleagues at Imperial College London and Invicro, a precision medicine company, reveal a clear communication pathway between cholinergic neurons and dopaminergic neurons, two major neurotransmitter systems found in the brain.

Dopaminergic neurons produce dopamine, but in Parkinson's disease, these levels are reduced as neurons deactivate and eventually die. This can cause a number of symptoms, including impaired movement.

Using a type of gene therapy in a rat model of Parkinson's, Dr Pienaar and her colleagues targeted cholinergic neurons, only to realise that a therapeutic knock-on effect was also felt by dopaminergic neurons. The originally stimulated cell was able to evoke a positive reaction in the receptive cell type, restoring dopaminergic functions.

With both groups of nerve cells stimulated, test subjects were seen to make a complete recovery including showing no more signs of movement and postural impairment.

Dr Ilse Pienaar, senior author of the study funded by the Medical Research Council, said: "When we used brain imaging, we found that as we activated cholinergic neurons, they then interacted directly with dopaminergic neurons.

"This seems to be a knock-on effect so by targeting this one set of neurons, we now know that we are able to also stimulate dopaminergic neurons, effectively restarting the production of dopamine and reducing symptoms.

"This is really important as it reveals more about how nerve systems in the brain interact, but also that we can successfully target two major systems which are affected by Parkinson's disease, in a more precise manner."

In the gene therapy technique, the team used a harmless virus to deliver a genetic modification to cholinergic neurons in rats rendered Parkinsonian. They then administered a drug designed to act as a 'switch' and stimulate target neurons.

The technique could, in future, provide a less invasive and more effective way to treat Parkinson's patients. While the disease can currently be managed by drugs, these tend to become ineffective after five years and present a number of side effects. An alternative is an invasive surgical procedure called deep brain stimulation (DBS) which uses electrodes to send pulses into the brain. However, this treatment produces mixed results and researchers believe this is because it stimulates every cell type rather than just the specific cells affected by Parkinson's disease.

Dr Pienaar said: "For the highest chance of recovery, treatments need to be focused and targeted but that requires a lot more research and understanding of exactly how Parkinson's operates and how our nerve systems work.

"Discovering that both cholinergic and dopaminergic neurons can be successfully targeted together is a big step forward.

"While this sort of gene therapy still needs to be tested on humans, our work can provide a solid platform for future bioengineering projects."

Lisa Wells, Head of CNS Discovery Applications at Invicro and co-author of this study commented: "It has been an exciting journey working with Dr Pienaar's team to combine the two technologies to offer us a powerful molecular approach to modify neuronal signaling and measure neurotransmitter release. We can support the clinical translation of this "molecular switch" into clinical utility through live imaging technology."

According to Parkinson's UK, around 145,000 people in the UK are diagnosed with the disease, which has three main symptoms -shaking, slowness of movement and muscle stiffness.

University of Sussex

Related Neurons Articles from Brightsurf:

Paying attention to the neurons behind our alertness
The neurons of layer 6 - the deepest layer of the cortex - were examined by researchers from the Okinawa Institute of Science and Technology Graduate University to uncover how they react to sensory stimulation in different behavioral states.

Trying to listen to the signal from neurons
Toyohashi University of Technology has developed a coaxial cable-inspired needle-electrode.

A mechanical way to stimulate neurons
Magnetic nanodiscs can be activated by an external magnetic field, providing a research tool for studying neural responses.

Extraordinary regeneration of neurons in zebrafish
Biologists from the University of Bayreuth have discovered a uniquely rapid form of regeneration in injured neurons and their function in the central nervous system of zebrafish.

Dopamine neurons mull over your options
Researchers at the University of Tsukuba have found that dopamine neurons in the brain can represent the decision-making process when making economic choices.

Neurons thrive even when malnourished
When animal, insect or human embryos grow in a malnourished environment, their developing nervous systems get first pick of any available nutrients so that new neurons can be made.

The first 3D map of the heart's neurons
An interdisciplinary research team establishes a new technological pipeline to build a 3D map of the neurons in the heart, revealing foundational insight into their role in heart attacks and other cardiac conditions.

Mapping the neurons of the rat heart in 3D
A team of researchers has developed a virtual 3D heart, digitally showcasing the heart's unique network of neurons for the first time.

How to put neurons into cages
Football-shaped microscale cages have been created using special laser technologies.

A molecule that directs neurons
A research team coordinated by the University of Trento studied a mass of brain cells, the habenula, linked to disorders like autism, schizophrenia and depression.

Read More: Neurons News and Neurons Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.